The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment -- with no signs of additional safety risks, a new study finds. Gleevec -- known generically as imatinib ...
Nonadherence to Gleevec in GIST patients is common, with cognitive functioning, TDM, and social support as key indicators. A machine learning model using 64 covariates identified 19 significant ...
The generic manufacturer may try to maximize profits during the initial exclusivity period, says an expert from a leading health plan. Sun Pharmaceuticalās product Imatinib Mesylate, the generic ...
For decades, medical science has developed new treatments and medications to battle cancer, cautiously hoping that somewhere out there lies a "magic bullet"--a cure. Several weeks ago, for a time, it ...
Novartis' first rule of innovation -- forget the forecasts, focus on the science. In the video below, analyst Max Macaluso and Bernard Munos, founder of the InnoThink Center for Research in Biomedical ...
FRIDAY, May 19, 2017 -- A leukemia drug might also effectively treat severe asthma, a small-scale clinical trial suggests. Gleevec (imatinib) reduced the "twitchiness" of airways, making them less ...
Gleevec, the daily pill that turned a killer type of leukemia into a manageable disease, may also help slow the worsening of diabetes, researchers reported Monday. In a follow up to a 2008 study in ...
- Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings EAST HANOVER, N.J., August 27, 2008 ...
The team notes, "Taken together, Gleevec exhibits greater beneficial effects on both glucose/lipid metabolism and energy homeostasis by blocking PPARĪ³ phosphorylation." They continue, "These data ...
Wonder drug Gleevec can keep cancer patients alive longer. But can it keep the costs down? Imatinib mesylate, commercially sold as Gleevec, has been found out to extend the lives of blood cancer ...
Novartis' breakthrough drug Gleevec revolutionized the treatment of chronic myeloid leukemia in 2001. Its success raised hopes that a wave of targeted drugs would have similar impacts on common tumors ...
Though enormously successful, the leukemia drug Gleevec has some downsides. Studies have linked the drug to heart failure in a small number of patients, and drug resistance can be a problem. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results